Analyst upgrades and price targets for Arcturus Therapeutics stock were reported on July 9, 2026, alongside stock price movement below its 50-day average.
2 reports, 2 independent
Updated Jul 18
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst upgrades and price targets for Arcturus Therapeutics stock were reported on July 9, 2026, alongside stock price movement below its 50-day average.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Arcturus Therapeutics
biotech company